Hepatitis C virus (HCV) infects more than 170 million people globally and is a leading cause of liver cirrhosis, transplantation and hepatocellular carcinoma. Current gold-standard therapy often fails, has significant side effects in many cases and is expensive. No vaccine is currently available. The fact that a significant proportion of infected people spontaneously control HCV infection in the setting of an appropriate immune response suggests that a vaccine for HCV is a realistic goal. A c...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Vaccination for hepatitis C virus: closing in on an evasive target.
If you are the owner of this record, you can report an update to it here: Report update to this record